Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial.

Shengxu ShaWenhao QiaoRenxiang FengGuodong LianYuezhi ChenLipan PengJunke WangLeping LiFeng TianChangqing Jing

Published in: Journal of cancer research and clinical oncology (2023)

Postoperative treatment with a somatostatin analog reduced the incidence of POPF and short-term complications after radical gastrectomy. (TRN: ChiCTR2200056201, Reg. Date: 2022/2/1).

Keyphrases

neuroendocrine tumors
patients undergoing
risk factors
study protocol
open label
randomized controlled trial
clinical trial
double blind